RESEARCH NOTICE & LEGAL DISCLAIMER
FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.
-
Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
-
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
-
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.
TB500
(10mg)
HIGHLIGHTS
TB-500 10 MG — RECONSTITUTION & RESEARCH MEASUREMENT GUIDE
For laboratory research and educational reference only.
Compound: TB-500
Vial Content: 10 mg
Diluent Volume: 3.0 mL bacteriostatic water
Final Concentration: Approximately 3.33 mg/mL
TB-500 10 MG — RECONSTITUTION & RESEARCH MEASUREMENT GUIDE
For laboratory research and educational reference only.
Compound: TB-500
Vial Content: 10 mg
Diluent Volume: 3.0 mL bacteriostatic water
Final Concentration: Approximately 3.33 mg/mL
CONCENTRATION CALCULATION
10 mg ÷ 3.0 mL = approximately 3.33 mg/mL
Using a U-100 insulin syringe for laboratory measurement:
1 unit = 0.01 mL
1 unit contains approximately 33.3 mcg
15 units = 0.15 mL = approximately 500 mcg
18 units = 0.18 mL = approximately 600 mcg
22.5 units = 0.225 mL = approximately 750 mcg
30 units = 0.30 mL = approximately 1,000 mcg
RESEARCH MEASUREMENT TABLE
Target QuantitySyringe UnitsLiquid Volume
500 mcg15 units0.15 mL
600 mcg18 units0.18 mL
750 mcg22.5 units0.225 mL
1,000 mcg30 units0.30 mL
Measurements are approximate because the prepared concentration is 3.33 mg/mL. Use appropriately calibrated laboratory equipment where greater precision is required.
RECONSTITUTION STEPS
-
Draw 3.0 mL of bacteriostatic water using a sterile syringe.
-
Slowly introduce the diluent down the inside wall of the vial. Avoid directing a forceful stream onto the lyophilized material.
-
Gently swirl or roll the vial until the material has dissolved. Do not shake.
-
Label the vial with:
-
Compound name
-
Final concentration: approximately 3.33 mg/mL
-
Reconstitution date
-
Applicable storage information
-
-
Store the reconstituted material refrigerated at 2–8 °C and protected from direct light. Do not freeze the reconstituted solution.
SUPPLY CALCULATIONS
Each 10 mg vial requires approximately 3.0 mL of bacteriostatic water.
4 vials require 12 mL
7 vials require 21 mL
10 vials require 30 mL
Suggested bacteriostatic-water quantities:
4 vials: 2 × 10 mL bottles
7 vials: 3 × 10 mL bottles
10 vials: 3 × 10 mL bottles
IMPORTANT RESEARCH-USE NOTICE
TB-500 is not approved by the FDA for human therapeutic use. This guide provides concentration, reconstitution and laboratory measurement information only. It is not medical advice and does not provide a treatment, administration or self-injection protocol. The material should be handled only by suitably qualified personnel in an appropriate research environment.